• Public Reporting

     

    ACO Name and Location

    Millennium Accountable Care Organization
    6321 Daniels Parkway, Suite 201
    Fort Myers, FL 33912

    Also Known As: ProCare Med, LLC

    ACO Primary Contact

    Gale Pearce, Executive Director
    E-mail: gpearce@mpgus.com
    Phone: 1-855-674-7400 (ext. 106)

    ACO Participants

    – Millennium Physician Group

    – University Family Healthcare, P.A.

    *No participants are involved in a joint venture between ACO professionals and hospitals

    Millennium Accountable Care Organization Governing Body

    – Brian Fox, Voting Member and Chairman, Millennium Physician Group

    – Kevin Kearns, Voting Member and Director, Millennium Physician Group

    – Geurt Peet, Voting Member and Director, Millennium Physician Group

    – Roy McKinley, Voting Member and Director, Millennium Physician Group

    – Juan Rivera, M.D., Voting Member and Director, Millennium Physician Group

    – Larry Scoggins, Voting Member and Medicare Beneficiary

    Key ACO Clinical and Administrative Leadership:

    Key Leadership:

    Gale Pearce, ACO Executive

    Todd Gannon, Chief Analytics Officer

    Tina Tolliver, Chief Compliance Officer

    Jeffrey Nelson, Chief Information Officer

    Dana McCalley, Quality Assurance/ Improvement Officer

    Mary Ann Perez Rose, Clinical Programs

    Associated Committees and Committee Leadership:

    Quality Oversight:

    David McAtee, D.O., Committee Lead

    Care Coordination:

    Juan Rivera, M.D.  Committee Lead

    Participant: 

    Alejandro Perez-Trepichio, M.D.

    Medical Directors and Physician Executive Council: 

    David McAtee, D.O.

    Alejandro Perez-Trepichio, M.D.

    Juan Rivera, M.D.

    Finance:

    Todd Gannon, Chief Analytics Officer

    Compliance:

    Tina Toliver, Chief Compliance Officer

    Types of ACO participants, or combinations of participants, that formed the ACO:

    • ACO professionals in a group practice arrangement
    •  Networks of individual practices of ACO professionals

    Shared Savings and Losses

    Amount of Shared Savings/Losses

    • Second Agreement Period
      • Performance Year 2016, $18,530,680
    • First Agreement Period
      • Performance Year 2015, $17,636,121
      • Performance Year 2014, $7,977,169
      • Performance Year 2013, $3,800,090

    Shared Savings Distribution

    • Second Agreement Period
      • Performance Year 2016
        • Proportion invested in infrastructure: 15%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 65%
    • First Agreement Period
      • Performance Year 2015
        • Proportion invested in infrastructure: 15%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 65%
      • Performance Year 2014
        • Proportion invested in infrastructure: 15%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 65%
      • Performance Year 2013
        • Proportion invested in infrastructure: 15%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 65%

    Quality Performance Results

    ACO# Measure Name Rate ACO Mean
    ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 81.12 80.51
    ACO-2 CAHPS: How Well Your Providers Communicate 93.39 93.01
    ACO-3 CAHPS: Patients’ Rating of Provider 93.44 92.25
    ACO-4 CAHPS: Access to Specialists 84.68 83.49
    ACO-5 CAHPS: Health Promotion and Education 65.29 60.32
    ACO-6 CAHPS: Shared Decision Making 76.30 75.40
    ACO-7 CAHPS: Health Status/Functional Status 75.38 72.30
    ACO-34 CAHPS: Stewardship of Patient Resources 27.45 26.97
    ACO-8 Risk Standardized, All Condition Readmission 13.95 14.70
    ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.64 18.17
    ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 44.40 53.20
    ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 58.85 75.23
    ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 49.39 59.81
    ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 7.41 9.27
    ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 12.66 14.53
    ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 95.41 82.72
    ACO-39 Documentation of Current Medications in the Medical Record 98.89 87.54
    ACO-13 Falls: Screening for Future Fall Risk 85.90 64.04
    ACO-14 Preventive Care and Screening: Influenza Immunization 80.35 68.32
    ACO-15 Pneumonia Vaccination Status for Older Adults 83.01 69.21
    ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 90.98 74.45
    ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 99.35 90.98
    ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 80.14 53.63
    ACO-19 Colorectal Cancer Screening 62.02 61.52
    ACO-20 Breast Cancer Screening 80.60 67.61
    ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 48.62 76.79
    ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease 77.73 77.72
    ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 8.72 18.24
    ACO-41 Diabetes: Eye Exam 46.22 44.94
    ACO-28 Hypertension (HTN): Controlling High Blood Pressure 81.51 70.69
    ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 88.93 85.05
    ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 79.08 88.67
    ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 82.94 79.67

    Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

    Note: In the Quality Performance Results file(s) above, search for “ProCare Med, LLC” or “Millennium Accountable Care Organization, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A07870 in the public use files on data.cms.gov.

    Payment Rule Waivers

    • Yes, our ACO does use the SNF 3-Day Rule Waiver